Canopy Growth Corp Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Canopy Growth Corp (CGC) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of CAD 688.63 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 688.63M CAD.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 697.59M CAD.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 747.13M CAD; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed 758.17M CAD.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 720.69M CAD; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed 736.01M CAD.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | 688.63M CAD 10-Q · filed 2026-08-07 | |
| 2026-03-31 | 697.59M CAD 10-Q · filed 2026-08-07 | |
| 2025-12-31 | 747.13M CAD 10-K · filed 2026-06-15 | 758.17M CAD 10-Q · filed 2026-02-06 |
| 2025-09-30 | 720.69M CAD 10-K · filed 2026-06-15 | 736.01M CAD 10-Q · filed 2025-11-07 |
| 2025-06-30 | 477.00M CAD 10-Q · filed 2026-08-07 | 488.98M CAD 10-Q · filed 2025-08-08 |
| 2025-03-31 | 478.57M CAD 10-Q · filed 2026-08-07 | 487.21M CAD 10-K · filed 2025-05-30 |
| 2024-12-31 | 558.00M CAD 10-K · filed 2026-06-15 | 591.48M CAD 10-Q · filed 2025-02-07 |
| 2024-09-30 | 464.31M CAD 10-K · filed 2026-06-15 | 509.67M CAD 10-Q · filed 2024-11-08 |
| 2024-06-30 | 467.12M CAD 10-K · filed 2026-06-15 | 532.92M CAD 10-Q · filed 2024-08-09 |
| 2024-03-31 | 400.57M CAD 10-K · filed 2026-06-15 | 500.51M CAD 10-K · filed 2024-05-30 |
| 2023-12-31 | 535.14M CAD 10-K · filed 2026-06-15 | 544.66M CAD 10-Q · filed 2024-02-09 |
| 2023-09-30 | 728.80M CAD 10-K · filed 2026-06-15 | 749.46M CAD 10-Q · filed 2023-11-09 |
| 2023-06-30 | 847.50M CAD 10-Q · filed 2025-02-07 | |
| 2023-03-31 | 760.02M CAD 10-K · filed 2026-06-15 | |
| 2022-12-31 | 1.36B CAD 10-Q · filed 2024-02-09 | 1.43B CAD 10-Q · filed 2023-02-09 |
| 2022-09-30 | 1.55B CAD 10-Q · filed 2024-02-09 | 1.63B CAD 10-Q · filed 2022-11-09 |
| 2022-06-30 | 1.64B CAD 10-Q · filed 2023-08-09 | 1.65B CAD 10-Q · filed 2022-08-09 |
| 2022-03-31 | 3.59B CAD 10-K · filed 2025-05-30 | 3.59B CAD 10-K · filed 2022-05-31 |
| 2021-12-31 | 4.14B CAD 10-Q · filed 2023-02-09 | |
| 2021-09-30 | 4.25B CAD 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 4.15B CAD 10-Q · filed 2022-08-09 | |
| 2021-03-31 | 3.49B CAD 10-K · filed 2024-05-30 | |
| 2020-12-31 | 4.18B CAD 10-Q · filed 2022-02-09 | |
| 2020-09-30 | 5.07B CAD 10-Q · filed 2021-11-08 | |
| 2020-06-30 | 5.18B CAD 10-Q · filed 2021-08-06 | |
| 2020-03-31 | 5.11B CAD 10-K · filed 2023-06-22 | |
| 2019-12-31 | 6.18B CAD 10-Q · filed 2021-02-09 | |
| 2019-09-30 | 6.20B CAD 10-Q · filed 2020-11-09 | |
| 2019-06-30 | 5.81B CAD 10-Q · filed 2020-08-10 | |
| 2019-03-31 | 7.07B CAD 10-K · filed 2022-05-31 | |
| 2018-03-31 | 1.13B CAD 10-K · filed 2021-06-01 | |
| 2017-03-31 | 596.16M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |